Alzheimer's disease: new therapies and the role of biomarkers
Biomarkers have shown promise for identifying people at high risk for Alzheimer's disease. Therapies that address presymptomatic disease are already in development, and MCOs should start thinking about coverage for them.
Gespeichert in:
| Veröffentlicht in: | Biotechnology healthcare 2011, Vol.8 (1), p.22-23 |
|---|---|
| 1. Verfasser: | |
| Format: | Magazinearticle |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Biomarkers have shown promise for identifying people at high risk for Alzheimer's disease. Therapies that address presymptomatic disease are already in development, and MCOs should start thinking about coverage for them. |
|---|---|
| ISSN: | 1554-169X |